Hipertrófiás kardiomiopátia: vizsgálatok itt: Csehország
3 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in CsehországStudy of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
- Where
- Prague
- Életkor
- 6 év and over
- People
- 26 worldwide
- Run by
- Lexeo Therapeutics
See details and how to joinNCT07721025 · EU 2025-524970-40-00 - 2/3. fázisTaking peopleOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- Prague
- Életkor
- 18 év to 85 év
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00 - No phaseVisszavonvaA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Olomouc, Prague
- Életkor
- 18 év and over
- People
- 1700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705